Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstractEva Segelov, Elizabeth Ahern, Amy Body et al.|Cancer Research|2022Cited by 0
Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNETEva Segelov, Elizabeth Ahern, Katie E. Lineburg et al.|Cancer Research|2022Cited by 0